Urogenital Neoplasms

• CLINICAL_TRIALS research · 2025-06-27
  Clinical Trial Update: Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy

  A clinical trial update examines the significance of adherent perinephric fat for patients undergoing partial nephrectomy, with the study cu…

• CLINICAL_TRIALS withdrawal · 2022-03-29
  Clinical Trial Update: Trial of NanoPac Focal Therapy for Prostate Cancer [Phase 2]

  A Phase 2 trial of NanoPac focal therapy for prostate cancer was terminated with results posted.

• CLINICAL_TRIALS trial_result · 2021-06-11
  Clinical Trial Update: Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) [Phase 1, Phase 2]

  Clinical trial update on tislelizumab in combination with BCG for high-risk non-muscle invasive bladder cancer (HR-NMIBC) across Phase 1 and…

• CLINICAL_TRIALS trial_result · 2020-11-25
  Clinical Trial Update: Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]

  Phase 2 trial evaluating an individualized treatment strategy for patients with metastatic non-clear cell renal cell carcinoma is ongoing, s…

• CLINICAL_TRIALS trial_result · 2017-04-19
  Clinical Trial Update: The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery [Phase 4]

  This Phase 4 study update investigates how the rate of albumin infusion affects plasma volume expansion after major abdominal surgery.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2015-04-01
  Clinical Trial Update: SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I [Phase 3]

  Phase 3 trial SHTC EUROPE-1 evaluating Synergo hyperthermia-chemotherapy for urinary bladder neoplasms has been withdrawn.